Cargando…

Visual outcome after posterior uveal melanoma episcleral brachytherapy including radiobiological doses

PURPOSE: To assess the long-term influence of radiobiological doses in the evolution of visual acuity (VA) in patients with uveal melanoma treated by episcleral brachytherapy. MATERIAL AND METHODS: Visual acuity was evaluated prospectively from a case series of 243 patients in 2016 treated with (125...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miguel, David, de Frutos-Baraja, Jesús María, López-Lara, Francisco, Antonia Saornil, María, García-Alvarez, Ciro, Alonso, Pilar, Diezhandino, Patricia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2018
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961527/ https://www.ncbi.nlm.nih.gov/pubmed/29789761 http://dx.doi.org/10.5114/jcb.2018.75597

Ejemplares similares

A study comparing baseline and best-corrected visual acuity after iodine-125 episcleral brachytherapy in uveal melanoma
por: Miguel, David, et al.
Publicado: (2023)

Bilateral episcleral brachytherapy in simultaneous choroidal melanoma and circumscribed hemangioma
por: Correa-Pérez, María Encarnación, et al.
Publicado: (2013)

Radiobiological doses, tumor, and treatment features influence on outcomes after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part II
por: Miguel, David, et al.
Publicado: (2018)

Radiobiological doses, tumor, and treatment features influence on local control, enucleation rates, and survival after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part I
por: Miguel, David, et al.
Publicado: (2018)

Regression of posterior uveal melanoma following iodine-125 plaque radiotherapy based on pre-treatment tumor apical height
por: Miguel, David, et al.
Publicado: (2021)

Treatment planning considerations for (125)I eye plaque brachytherapy
por: Miguel, David, et al.
Publicado: (2019)

Radiobiological evaluation of organs at risk for electronic high-dose-rate brachytherapy in uveal melanoma: a radiobiological modeling study
por: Waldron, Timothy J., et al.
Publicado: (2021)

Evaluation of the surgical learning curve for I-125 episcleral plaque placement for the treatment of posterior uveal melanoma: a two decade review
por: Shah, Nisha V, et al.
Publicado: (2012)

Brachytherapy of Uveal Melanomas with Ruthenium-106 Plaques
por: Belaïd, Asma, et al.
Publicado: (2016)

Ruthenium brachytherapy for uveal melanoma – single institution experience
por: Rospond-Kubiak, Iwona, et al.
Publicado: (2017)

Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma
por: Lonngi, Marcela, et al.
Publicado: (2013)

Clinical Outcomes after Surgical Resection Combined with Brachytherapy for Uveal Melanomas
por: Relimpio-López, Isabel, et al.
Publicado: (2022)

Long-Term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy
por: Cennamo, Gilda, et al.
Publicado: (2022)

Episcleritis
por: Cotter, R. O.
Publicado: (1887)

Forty-year prognosis after plaque brachytherapy of uveal melanoma
por: Stålhammar, Gustav
Publicado: (2020)

Radiation retinopathy following episcleral brachytherapy for intraocular tumors: Current treatment options
por: Mularska, Weronika, et al.
Publicado: (2023)

Staged Eye-Plaque Brachytherapy: A Novel Approach for Large Uveal Melanoma
por: Chevli, Neil, et al.
Publicado: (2021)

Intra-operative ocular ultrasonography of iodine-125 brachytherapy plaques in patients with uveal melanoma
por: Ces, Antonio Piñeiro, et al.
Publicado: (2021)

Monte Carlo dosimetry of a novel Yttrium‐90 disc source for episcleral brachytherapy
por: Chang, Xiangyun, et al.
Publicado: (2023)

Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions
por: Brewington, Beatrice Y, et al.
Publicado: (2018)

Regression patterns of uveal melanoma after iodine-125 plaque brachytherapy
por: Fang, Rui, et al.
Publicado: (2021)

Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma
por: Tagliaferri, Luca, et al.
Publicado: (2017)

(106)Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma
por: Jiang, Ping, et al.
Publicado: (2020)

Silicone Oil and Iodine-125 Brachytherapy for Uveal Melanoma in High-Risk Patients
por: Lyons, Lance J, et al.
Publicado: (2019)

Impact of COVID-19 on a rare disease (uveal melanoma) in a national reference unit of intraocular tumors in Spain
por: Bermudez-Castellanos, I., et al.
Publicado: (2023)

Clinical application of genetic testing for posterior uveal melanoma
por: Schopper, Victoria J., et al.
Publicado: (2016)

Posterior uveal melanoma in adolescents and children: current perspectives
por: Fry, Matthew V, et al.
Publicado: (2018)

Recurrent Tubercular Episcleritis
por: Alnahdi, Muhannad A., et al.
Publicado: (2021)

Paired comparisons of mutational profiles before and after brachytherapy in asian uveal melanoma patients
por: Lee, Woo Seung, et al.
Publicado: (2021)

Prognosis Prediction of Uveal Melanoma After Plaque Brachytherapy Based on Ultrasound With Machine Learning
por: Luo, Jingting, et al.
Publicado: (2022)

A Prognostic Score for the Prediction of Local Treatment Failure in Plaque Brachytherapy of Uveal Melanoma
por: Kal Omar, Ruba, et al.
Publicado: (2022)

MR-based follow-up after brachytherapy and proton beam therapy in uveal melanoma
por: Tang, Michael C. Y., et al.
Publicado: (2023)

The T1799A point mutation is present in posterior uveal melanoma
por: Janssen, C S, et al.
Publicado: (2008)

Stereotactic Ablative Brachytherapy: Recent Advances in Optimization of Radiobiological Cancer Therapy
por: Xue, Hui, et al.
Publicado: (2021)

Pigment Epithelium Macroadenoma Mimicking Iris or Ciliary Body Melanoma
por: Sánchez-Tabernero, Sara, et al.
Publicado: (2021)

Efficacy and complications of ruthenium-106 brachytherapy for uveal melanoma: a systematic review and meta-analysis
por: Karimi, Saeed, et al.
Publicado: (2021)

Reoccurring Episcleritis and the Role of Antioxidants
por: Goyal, Lokesh, et al.
Publicado: (2022)

Episcleritis; and posterior uveitis misdiagnosed as orbital cellulitis in a child patient with Behçet’s disease
por: Jari, Mohsen, et al.
Publicado: (2023)

Uveal Melanoma
por: Papastefanou, Vasilios P., et al.
Publicado: (2011)

Uveal Melanoma
por: Pfeffer, Ulrich
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qh7hvia066ket99oftenq10j3f